Physician profile
Don K Moore
NPI 1255302261
$18,479.56
in general payments reported to CMS, 2019-2025
17 companies · $595 in 2025
The $595 reported for 2025 was less than what a typical Orthopaedic Surgery of The Spine provider received nationally (typical 2025 total: $2,116).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,744 · 2020: $1,211 · 2021: $249 · 2022: $2,115 · 2023: $8,291 · 2024: $4,274 · 2025: $595.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $10K · Food and Beverage: $2,720.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $10,440.76 |
| Food and Beverage | $2,719.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $10,211.23 | 2019-2024 | Excelsius3d Imaging System, Excelsiusgps Robotic Navigation System, Rise |
| Medtronic, INC. | $2,946.77 | 2022-2025 | Pivox Oblique Lateral Spinal System, Kyphon Express II Kyphopak Tray, Mazor X System |
| Elite Orthopedics, LLC | $1,895.87 | 2023-2025 | |
| Medtronic USA, INC. | $1,535.95 | 2019-2020 | |
| Arthrex, INC. | $1,008.70 | 2024 | |
| Amplify Surgical, INC. | $229.40 | 2024 | Dualx and Dual Portal |
| Cerapedics INC. | $117.79 | 2025 | I-Factor Peptide Enhanced Bone Graft |
| Depuy Synthes Sales INC. | $113.30 | 2021-2022 | |
| Biocomposites INC | $98.98 | 2024 | |
| Merck Sharp & Dohme LLC | $93.80 | 2023 | |
| Augmedics INC. | $83.55 | 2021 | |
| Abbott Laboratories | $64.72 | 2024 | Eterna |
| Orthofix Medical, INC. | $29.28 | 2022-2024 | Cervical-Stim |
| Grifols USA, LLC | $19.42 | 2023 | Prolastin-C Liquid |
| Zimmer Biomet Holdings, INC. | $17.48 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $13.32 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Don Moore listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.